Quidel ROA 2006-2019 | QDEL

Current and historical return on assets (ROA) values for Quidel (QDEL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Quidel ROA for the three months ending March 31, 2019 was 12.73%.
Quidel ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-03-31 $0.07B $0.91B 7.95%
2018-12-31 $0.07B $0.81B 9.16%
2018-09-30 $0.04B $0.79B 4.41%
2018-06-30 $0.02B $0.76B 2.69%
2018-03-31 $0.01B $0.87B 1.68%
2017-12-31 $-0.01B $0.94B -1.67%
2017-09-30 $-0.01B $0.41B -1.50%
2017-06-30 $-0.00B $0.40B -0.26%
2017-03-31 $0.00B $0.40B 0.78%
2016-12-31 $-0.01B $0.39B -3.70%
2016-09-30 $-0.01B $0.38B -3.13%
2016-06-30 $-0.01B $0.37B -3.05%
2016-03-31 $-0.01B $0.38B -3.18%
2015-12-31 $-0.01B $0.41B -1.40%
2015-09-30 $0.00B $0.42B 0.23%
2015-06-30 $-0.00B $0.43B -1.00%
2015-03-31 $-0.00B $0.46B -0.56%
2014-12-31 $-0.01B $0.45B -2.57%
2014-09-30 $-0.01B $0.27B -5.24%
2014-06-30 $-0.01B $0.26B -4.50%
2014-03-31 $-0.01B $0.27B -2.61%
2013-12-31 $0.01B $0.27B 2.64%
2013-09-30 $0.02B $0.27B 5.83%
2013-06-30 $0.02B $0.27B 7.19%
2013-03-31 $0.02B $0.26B 7.02%
2012-12-31 $0.01B $0.24B 2.11%
2012-09-30 $-0.00B $0.24B -1.22%
2012-06-30 $-0.00B $0.23B -1.17%
2012-03-31 $-0.00B $0.24B -1.53%
2011-12-31 $0.01B $0.28B 2.62%
2011-09-30 $0.01B $0.27B 2.39%
2011-06-30 $0.00B $0.25B 0.42%
2011-03-31 $0.00B $0.26B 1.32%
2010-12-31 $-0.01B $0.22B -4.99%
2010-09-30 $0.01B $0.21B 4.32%
2010-06-30 $0.03B $0.22B 15.58%
2010-03-31 $0.03B $0.23B 19.76%
2009-12-31 $0.03B $0.17B 23.57%
2009-09-30 $0.02B $0.15B 14.15%
2009-06-30 $0.01B $0.12B 6.72%
2009-03-31 $0.01B $0.13B 5.09%
2008-12-31 $0.02B $0.14B 13.60%
2008-09-30 $0.02B $0.15B 15.27%
2008-06-30 $0.02B $0.13B 13.82%
2008-03-31 $0.02B $0.13B 13.55%
2007-12-31 $0.01B $0.13B 10.70%
2007-09-30 $0.02B $0.12B 19.21%
2007-06-30 $0.02B $0.11B 19.70%
2007-03-31 $0.02B $0.12B 18.22%
2006-12-31 $0.02B $0.13B 18.30%
2006-09-30 $0.01B $0.11B 11.66%
2006-06-30 $0.01B $0.11B 11.01%
2006-03-31 $0.01B $0.12B 13.40%
2005-12-31 $-0.01B $0.11B -8.74%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.233B $0.522B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.025B 26.02
Medtronic (MDT) Ireland $117.659B 17.20
Stryker (SYK) United States $68.704B 24.52
Boston Scientific (BSX) United States $51.899B 24.88
Baxter (BAX) United States $38.763B 24.43
Zimmer Biomet Holdings (ZBH) United States $23.843B 15.32
Smith & Nephew SNATS (SNN) United Kingdom $18.247B 0.00
ResMed (RMD) United States $16.172B 30.90
Canopy Growth (CGC) Canada $15.352B 0.00
Bio-Rad Laboratories (BIO) United States $8.842B 46.88
Aurora Cannabis (ACB) Canada $8.802B 86.80
Perrigo (PRGO) Ireland $6.755B 11.42
Hill-Rom Holdings (HRC) United States $6.504B 19.72
Insulet (PODD) United States $6.200B 451.74
GW Pharmaceuticals (GWPH) United Kingdom $5.280B 0.00
Haemonetics (HAE) United States $5.104B 41.87
ICU Medical (ICUI) United States $4.630B 27.62
Hutchison China MediTech (HCM) China $3.565B 0.00
NuVasive (NUVA) United States $3.164B 25.84
Neogen (NEOG) United States $3.071B 49.94
Agios Pharmaceuticals (AGIO) United States $2.941B 0.00
National Vision Holdings (EYE) United States $2.120B 45.18
Aphria (APHA) $1.712B 0.00
Cardiovascular Systems (CSII) United States $1.377B 790.80
Phibro Animal Health (PAHC) United States $1.168B 17.50
AtriCure (ATRC) United States $1.136B 0.00
VAREX IMAGING (VREX) United States $1.083B 22.98
Lantheus Holdings (LNTH) United States $0.941B 25.00
NanoString Technologies (NSTG) United States $0.941B 0.00
Omeros (OMER) United States $0.914B 0.00
MacroGenics (MGNX) United States $0.913B 0.00
PetIQ (PETQ) United States $0.806B 19.58
Cerus (CERS) United States $0.754B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.753B 21.11
TG Therapeutics (TGTX) United States $0.609B 0.00
LeMaitre Vascular (LMAT) United States $0.541B 26.20
OraSure Technologies (OSUR) United States $0.529B 24.37
Surmodics (SRDX) United States $0.527B 76.59
Quanterix (QTRX) United States $0.498B 0.00
Meridian Bioscience (VIVO) United States $0.462B 14.13
Evolus (EOLS) United States $0.440B 0.00
BioLife Solutions (BLFS) United States $0.343B 107.18
Utah Medical Products (UTMD) United States $0.311B 21.52
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.310B 0.00
Vapotherm (VAPO) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.267B 0.00
Zynex (ZYXI) United States $0.240B 24.80
Owens & Minor (OMI) United States $0.226B 4.79
Cytosorbents (CTSO) United States $0.223B 0.00
Bovie Medical (APYX) United States $0.204B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Chembio Diagnostics (CEMI) United States $0.134B 0.00
Fonar (FONR) United States $0.134B 7.05
Surface Oncology (SURF) United States $0.111B 0.00
Female Health (VERU) United States $0.103B 0.00
United-Guardian (UG) United States $0.094B 20.70
Neurotrope (NTRP) United States $0.091B 0.00
Insys Therapeutics (INSY) United States $0.079B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 20.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.042B 0.00
GUARDION HEALTH (GHSI) United States $0.032B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.029B 0.00
BRAINSWAY LTD (BWAY) Israel $0.027B 0.00
Valeritas Holdings (VLRX) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 4.60